TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T87831	N-formyl peptide receptor	B0G6BK	N-(1,3-Benzodioxol-5-yl)-2-[5-[(3-methoxyphenyl)methyl]-6-oxo-3-thiophen-2-ylpyridazin-1-yl]acetamide	Investigative	71698622	C25H21N3O5S	475.5	COC1=CC=CC(=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC4=C(C=C3)OCO4)C5=CC=CS5	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B0ID4L	N-(4-Iodophenyl)-2-(3-methyl-6-oxopyridazin-1-yl)acetamide	Investigative	71699141	C13H12IN3O2	369.16	CC1=NN(C(=O)C=C1)CC(=O)NC2=CC=C(C=C2)I	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B0NQJ8	2-[3-Benzyl-5-[(4-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]-N-(4-bromophenyl)acetamide	Investigative	71698878	C27H24BrN3O3	518.4	COC1=CC=C(C=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)Br)CC4=CC=CC=C4	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B0W7ZK	N-(4-Bromophenyl)-2-[3-(4-methoxyphenyl)-5-[(4-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]acetamide	Investigative	71698624	C27H24BrN3O4	534.4	COC1=CC=C(C=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)Br)C4=CC=C(C=C4)OC	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B0WG3B	4-Bromo-N-[2-[2-(4-bromoanilino)-2-oxoethyl]-6-methyl-3-oxopyridazin-4-yl]benzamide	Investigative	71699222	C20H16Br2N4O3	520.2	CC1=NN(C(=O)C(=C1)NC(=O)C2=CC=C(C=C2)Br)CC(=O)NC3=CC=C(C=C3)Br	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B51PNA	N-(4-Bromophenyl)-2-[5-[(3,5-dimethoxyphenyl)methyl]-3-methyl-6-oxopyridazin-1-yl]acetamide	Investigative	71698970	C22H22BrN3O4	472.3	CC1=NN(C(=O)C(=C1)CC2=CC(=CC(=C2)OC)OC)CC(=O)NC3=CC=C(C=C3)Br	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B5GP8J	N-(1,3-Benzodioxol-5-yl)-2-[5-[(3-methoxyphenyl)methyl]-3-(4-methylphenyl)-6-oxopyridazin-1-yl]acetamide	Investigative	71698794	C28H25N3O5	483.5	CC1=CC=C(C=C1)C2=NN(C(=O)C(=C2)CC3=CC(=CC=C3)OC)CC(=O)NC4=CC5=C(C=C4)OCO5	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B6TLO2	N-(4-Fluorophenyl)-2-[5-[(3-methoxyphenyl)methyl]-6-oxo-3-thiophen-2-ylpyridazin-1-yl]acetamide	Investigative	71698623	C24H20FN3O3S	449.5	COC1=CC=CC(=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)F)C4=CC=CS4	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B7KP2N	N-(4-Fluorophenyl)-2-[3-(4-methoxyphenyl)-5-[(3-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]acetamide	Investigative	71698710	C27H24FN3O4	473.5	COC1=CC=C(C=C1)C2=NN(C(=O)C(=C2)CC3=CC(=CC=C3)OC)CC(=O)NC4=CC=C(C=C4)F	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B7QI6T	N-(4-Bromophenyl)-2-[3-(4-fluorophenyl)-5-[(4-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]acetamide	Investigative	71698796	C26H21BrFN3O3	522.4	COC1=CC=C(C=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)Br)C4=CC=C(C=C4)F	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	B9ZJ7N	N-(4-Fluorophenyl)-2-[3-(4-fluorophenyl)-5-[(3-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]acetamide	Investigative	71698877	C26H21F2N3O3	461.5	COC1=CC=CC(=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)F)C4=CC=C(C=C4)F	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BDG7I3	N-(4-Bromophenyl)-2-[5-[(3-bromophenyl)methyl]-3-methyl-6-oxopyridazin-1-yl]acetamide	Investigative	71698969	C20H17Br2N3O2	491.2	CC1=NN(C(=O)C(=C1)CC2=CC(=CC=C2)Br)CC(=O)NC3=CC=C(C=C3)Br	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BF9E3R	N-(4-Fluorophenyl)-2-[5-[(3-methoxyphenyl)methyl]-3-(4-methylphenyl)-6-oxopyridazin-1-yl]acetamide	Investigative	71698795	C27H24FN3O3	457.5	CC1=CC=C(C=C1)C2=NN(C(=O)C(=C2)CC3=CC(=CC=C3)OC)CC(=O)NC4=CC=C(C=C4)F	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BFYP42	N-(4-Bromophenyl)-2-[3-methyl-6-oxo-5-[[4-(trifluoromethyl)phenyl]methyl]pyridazin-1-yl]acetamide	Investigative	71698971	C21H17BrF3N3O2	480.3	CC1=NN(C(=O)C(=C1)CC2=CC=C(C=C2)C(F)(F)F)CC(=O)NC3=CC=C(C=C3)Br	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BJ8OE1	N-(4-Bromophenyl)-2-[5-[(4-cyanophenyl)methyl]-3-methyl-6-oxopyridazin-1-yl]acetamide	Investigative	71699064	C21H17BrN4O2	437.3	CC1=NN(C(=O)C(=C1)CC2=CC=C(C=C2)C#N)CC(=O)NC3=CC=C(C=C3)Br	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BJY27R	N-(1,3-Benzodioxol-5-yl)-2-[3-(4-methoxyphenyl)-5-[(3-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]acetamide	Investigative	71698709	C28H25N3O6	499.5	COC1=CC=C(C=C1)C2=NN(C(=O)C(=C2)CC3=CC(=CC=C3)OC)CC(=O)NC4=CC5=C(C=C4)OCO5	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BKJ6N8	N-(1,3-Benzodioxol-5-yl)-2-[5-[(3-methoxyphenyl)methyl]-6-oxo-3-phenylpyridazin-1-yl]acetamide	Investigative	71698532	C27H23N3O5	469.5	COC1=CC=CC(=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC4=C(C=C3)OCO4)C5=CC=CC=C5	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BM1YS4	N-(1,3-Benzodioxol-5-yl)-2-[3-(4-fluorophenyl)-5-[(3-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]acetamide	Investigative	71698797	C27H22FN3O5	487.5	COC1=CC=CC(=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC4=C(C=C3)OCO4)C5=CC=C(C=C5)F	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BMT6A8	2-[3-(4-Chlorophenyl)-5-[(3-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]-N-(4-fluorophenyl)acetamide	Investigative	71698713	C26H21ClFN3O3	477.9	COC1=CC=CC(=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)F)C4=CC=C(C=C4)Cl	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BN6S4C	2-(5-Benzyl-3-methyl-6-oxopyridazin-1-yl)-N-(4-fluorophenyl)acetamide	Investigative	71698881	C20H18FN3O2	351.4	CC1=NN(C(=O)C(=C1)CC2=CC=CC=C2)CC(=O)NC3=CC=C(C=C3)F	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BN9AK1	N-(1,3-Benzodioxol-5-yl)-2-[3-(4-chlorophenyl)-5-[(3-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]acetamide	Investigative	71698712	C27H22ClN3O5	503.9	COC1=CC=CC(=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC4=C(C=C3)OCO4)C5=CC=C(C=C5)Cl	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BPW6Z9	N-(4-Bromophenyl)-2-[5-[(4-methoxyphenyl)methyl]-6-oxo-3-thiophen-2-ylpyridazin-1-yl]acetamide	Investigative	71698621	C24H20BrN3O3S	510.4	COC1=CC=C(C=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)Br)C4=CC=CS4	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BSED83	N-(4-Bromophenyl)-2-[3-(4-chlorophenyl)-5-[(4-methoxyphenyl)methyl]-6-oxopyridazin-1-yl]acetamide	Investigative	71698711	C26H21BrClN3O3	538.8	COC1=CC=C(C=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)Br)C4=CC=C(C=C4)Cl	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BU1K8L	N-(4-Iodophenyl)-2-(3-methyl-6-oxo-4,5-dihydropyridazin-1-yl)acetamide	Investigative	71699140	C13H14IN3O2	371.17	CC1=NN(C(=O)CC1)CC(=O)NC2=CC=C(C=C2)I	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BYH07R	N-(4-Bromophenyl)-2-[5-[(4-methoxyphenyl)methyl]-3-(4-methylphenyl)-6-oxopyridazin-1-yl]acetamide	Investigative	71698793	C27H24BrN3O3	518.4	CC1=CC=C(C=C1)C2=NN(C(=O)C(=C2)CC3=CC=C(C=C3)OC)CC(=O)NC4=CC=C(C=C4)Br	EC50 ~ 50000 nM	Poor binder
T87831	N-formyl peptide receptor	BZ1V3C	N-(4-Fluorophenyl)-2-[5-[(3-methoxyphenyl)methyl]-6-oxo-3-phenylpyridazin-1-yl]acetamide	Investigative	71698620	C26H22FN3O3	443.5	COC1=CC=CC(=C1)CC2=CC(=NN(C2=O)CC(=O)NC3=CC=C(C=C3)F)C4=CC=CC=C4	EC50 ~ 50000 nM	Poor binder